Biotech · Private company · Durham, NC, US
Gateway Bio, Inc.
Track this companyFree. Adds Gateway Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Scale-up and Toxicity Studies of POEGMA-UricaseFiscal year 2026 · $735.3KNIH RePORTER 5R44TR003255-04 · fetched Nov 12, 2026
- Next Generation Stealth Lipid for the Delivery of mRNAFiscal year 2025 · $314.3KNIH RePORTER 1R41AI181391-01A1 · fetched Nov 12, 2026
- Novel Stealth Lipid for use in HIV MPER VaccineFiscal year 2025 · $303.2KNIH RePORTER 1R41AI195239-01 · fetched Nov 12, 2026
- Scale-up and Toxicity Studies of POEGMA-UricaseFiscal year 2025 · $639.4KNIH RePORTER 5R44TR003255-03 · fetched Nov 12, 2026
- Scale-up and Toxicity Studies of POEGMA-UricaseFiscal year 2024 · $639.2KNIH RePORTER 2R44TR003255-02 · fetched Nov 12, 2026